Using machine learning approaches, including TreeBagger and DNN, and E2F1–8 expression datasets, survival terms of GBM patients were successfully predicted and validated, emphasizing that these factors play a key role in tumor progression and patient survival. Here, E2F1 is linked to glioblastoma.